GLP-1
An informed starting point for a clinician-led conversation about prescription GLP-1 medicines and your health goals.
View detailsThe peptide edit
Injectable
Prescription options begin with a telehealth consultation and clinical review. This page provides information; it does not offer injectable products for purchase.
KPV
A focused guide for questions about KPV, human evidence and the claims you may encounter online. Educational information only.
View detailsGHK
Start by clarifying the name. A discussion of GHK should identify the exact compound and whether the context is topical or injectable.
View detailsTB500
An educational introduction to TB500 for readers comparing research language with claims about personal recovery.
View detailsBPC-157
A place to examine BPC-157 questions with a clear distinction between research interest and a personal treatment decision.
View detailsClinical review comes first
FDA approval applies to a specific drug product. Compounded medicines are not FDA-approved. A consultation does not guarantee a prescription.
FDA has identified limited safety information for BPC-157, KPV, injectable GHK-Cu and TB-500. Listing these topics here does not confirm their availability as POLI treatments.
Your next step
Begin with your goals.
Explore the questions you can bring to a consultation and the steps toward an informed decision.
Explore your next steps